|
Hopfer. S. (2010). College Women’s Decision Narratives of HPV Vaccine Acceptance and Resistance. Submitting to Health Communication (Target submission date: Fall 2009)
Hopfer, S. (2010). A mental models approach to understanding HPV vaccine decision behavior: Comparing motivations to comply among those already vaccinated and those intending to vaccinate. Submitting to: Vaccine (Target submission date: Fall 2009).
Hopfer, S. (2010). Validation of a daughter-parent vaccine communication scale for use in HPV vaccine prevention interventions. Submitting to Health Education & Behavior (Target submission date: Fall 2009).
Hopfer, S., Davis, D., Kam, J. A., Shin, Y., Elek, E., Hecht. M. L. (2009). A review of elementary school-based substance use prevention programs:Identifying Program Attributes Journal of Drug Education (under review).
Hopfer, S., Lee, J. K., Hecht, M. L. (2010). A latent class analysis of preadolescent drug resistance skill and its relationship to drug offers, a latent transition analysis of change in membership across developmental periods and its relationship to drug use. Submitting to Health Communication (Target submission date: Fall 2009).
Warren, J. R., Allen, M. L., Hopfer, S., Okuyemi, K. (in press). Contextualizing single-parent preadolescent drug use talks. Qualitative Research Reports in Communication.
Hecht, M. L. and Hopfer, S. (2010). Communication Theory of Identity in Jackson, R. L. II (Ed.) Encyclopedia of Identity, Thousand Oaks, CA: Sage.
Kugel, C., Retzlaff, C., Hopfer, S. Lawson, D., Daley, E., Drewes, C. Freedman, S. (2009). Familias con Voz: Community survey results from an intimate partner violence (IPV) prevention project with migrant workers. Journal of Family Violence, 24(8), 649-660.
Parrott, R. L., Volkman, J. E., Lengerich, E. J., Ghetian, C., Chadwick, A. E., Hopfer. S. (2009). Community involvement: Use of Geographic Information Systems for Comprehensive Cancer Control, Health Communication, in press.
Hopfer, S., Chadwick, A. E., Parrott, R. L., Ghetian, C. B., Lengerich, E. J. (2008). GIS Mapping in State Comprehensive Cancer Control Programs: Assessment of Training Needs and Preferences. Health Promotion and Practice, April 1, DOI:10.1177/1524839907309047
Volkman, J. E., Parrott, R. L., Hopfer, S., Lengerich, E. J. (2008) The meaning of privacy: The promise of GIS mapping and cancer control planning. Journal of Cancer Education, in press.
Hopfer, S., MacEachren, A. M. (2007). Leveraging the potential of geospatial annotations for group decisions: a communication theory perspective. International Journal of Geographic Information Systems, 8(21), 921-934.
Parrott, R. L., Hopfer, S., Ghetian, C. B., Lengerich, E. J. (2007). Mapping as Visual Health Communication Tool: Promises and Dilemmas. Health Communication, 22(1), 13-24.
Oliveira, J. R., Spiteri, E., Sobrido, M. J., Hopfer, S., Klepper, J., Voit, T., Gilbert, J., Wszolek, Z. K., Calne, D. B., Stoessl, A. J., Hutton, M., Manyam, B. V., Boller, F., Baquero, M., Geschwind, D. H. (2004). Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr’s disease or IBGC). Neurology, 63(11), 2165-7.
Hopfer, S., Varga, E. (2004). The pedigree before the pill. The Genetic Family History, 2(1), 5.
Hopfer, S. (2003). Emerging Issues in the Era of Genetic Testing. Generations, 31(1), Spring,1-5.
Sobrido, M. J., Hopfer, S., Geschwind, D. H. (2002). Idiopathic Basal Ganglia Calcification. GeneReviews: Genetic Disease Online Reviews April: www.geneclinics.org
Hopfer, S. and Sobrido, M. J. (2001). Counseling Considerations Unique to Predictive Genetic Testing for Familial Basal Ganglia Calcification (FBGC) also known as Fahr’s Disease. Journal of Genetic Counseling, 10(6), 436-437.
Hopfer, S. (2001). Book Review on the Ethics in Neurobiological Research with Human Subjects. Journal of Genetic Counseling, 10(5), 425-428.
Mansfield, C., Hopfer, S., Marteau, T. M. (1999). Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a Fetal Abnormality). Prenatal Diagnosis, 19(9), 808-812.
|